Probiotics for the prevention and treatment of Clostridium difficile in older patients

Islam, J, Cohen, J, Rajkumar, C and Llewelyn, M J (2012) Probiotics for the prevention and treatment of Clostridium difficile in older patients. Age and Ageing, 41 (6). pp. 706-711. ISSN 0002-0729

Full text not available from this repository.


Clostridium difficile infection (CDI) is the leading cause of nosocomial diarrhoea in older people, causing substantial morbidity and mortality. The fact that CDI is almost exclusively a disease of older people and the debilitated indicates that patient susceptibility is a major determinant of who gets CDI. It would help efforts to combat this disease if we better understood and could reduce patient susceptibility. In this regard, several strategies are currently under investigation. The use of probiotics for CDI has received particular attention in the medical and lay media. Patients and their carers often ask doctors about them. In this review article, we describe the pathogenesis of CDI before looking at the ageing host in more detail. We discuss how probiotics may work and review the current evidence for their use in CDI.

Item Type: Article
Additional Information: probiotics, Clostridium difficile, immunesenescence, antibiotic-associated diarrhoea, intestinal microflora, older people
Schools and Departments: Brighton and Sussex Medical School > Clinical and Experimental Medicine
Brighton and Sussex Medical School > Global Health and Infection
Subjects: R Medicine
Depositing User: Jonathan Cohen
Date Deposited: 17 Oct 2012 14:59
Last Modified: 25 Jan 2018 10:22
📧 Request an update